top of page
Search
All Posts
The “Ozempic Economy”: How Weight-Loss Drugs Are Reshaping U.S. Retail, Fast-Food, and Fitness Stocks Through New Consumer Spending Habits
FIG.1 - Image of Viral Ozempic Weight-loss Drug in U.S Pharmacy from Quartz As millions of Americans embrace the fad of weight-loss drugs, the effects are showing up not only on scales but in quarterly earnings as well. Glucagon-like peptide-1 (GLP-1) weight-loss medications such as Ozempic and Zepbound have captivated the country, with around 8-10 million Americans receiving prescriptions so far (PwC, 2024). These drugs work by suppressing hunger and reducing caloric intake
Tyler Caputo
Jan 227 min read
PayPal: A Value Play Positioned for Steady Long-Term Growth
I recommend buying PayPal ($PYPL) with a timeline of 1 year and beyond. While PayPal’s hyper-growth phase may be behind it, the company remains a dominant force in digital payments and a great value stock with steady growth for years to come. A key driver of this growth is Venmo, which many people do not realize is owned by PayPal. Additionally, PayPal’s expanding product lineup including debit cards and Buy Now, Pay Later solutions positions it for sustained revenue growth.
Nick Hardy
May 17, 20252 min read
bottom of page